Publications by authors named "C Burress"
Article Synopsis
- Vagus Nerve Stimulation (VNS) with rehabilitation was FDA-approved in 2021 for improving motor function in chronic stroke survivors with severe arm and hand impairments.
- The study involved 108 participants who underwent outpatient VNS implantation, with minimal complications noted, and most had recovery within 48 hours.
- The findings indicate that the Vivistim System has a favorable safety profile comparable to previous VNS treatments for epilepsy and depression, supporting its use in stroke patients.
The relationship between collective properties and performance of antiagglomerants (AAs) used in hydrate management is handled using molecular dynamics simulations and enhanced sampling techniques. A thin film of AAs adsorbed at the interface between one flat sII methane hydrate substrate and a fluid hydrocarbon mixture containing methane and n-dodecane is studied. The AA considered is a surface-active compound with a complex hydrophilic head that contains both amide and tertiary ammonium cation groups and hydrophobic tails.
View Article and Find Full Text PDFIn gas clathrate hydrates, inclusion gas molecules stabilize crystalline water structures. In addition to being fundamentally interesting, gas hydrates attract significant practical attention because of their possible application in various high-tech technologies. However, gas hydrates pose health, safety, and environmental risks when they form within oil and gas pipelines, as well as within hydrocarbon-producing and treatment facilities.
View Article and Find Full Text PDFThe aim of the pilot study was to evaluate the effect of Vagus Nerve Stimulation (VNS) paired with sounds in chronic tinnitus patients. All participants were implanted and randomized to a paired VNS (n = 16) or control (n = 14) group. After 6 weeks of home therapy, all participants received paired VNS.
View Article and Find Full Text PDFBackground: Sensory stimulation is often provided to persons incurring severe traumatic brain injury (TBI), but therapeutic effects are unclear.
Objective: This preliminary study investigated neurobehavioral and neurophysiological effects related to sensory stimulation on global neurobehavioral functioning, arousal, and awareness.
Methods: A double-blind randomized placebo-controlled trial where 15 participants in states of disordered consciousness (DOC), an average of 70 days after TBI, were provided either the Familiar Auditory Sensory Training (FAST) or Placebo of silence.